GenoFocus is a microbiome therapeutics platform company. We engage in identifying effector molecules that are now well-known as postbiotics in a bid to discover new drug candidates. By enhancing strains to better produce these effector molecules such as but not limited to SOD, Spore, etc., we develop a class of our own biological drugs. Our microbiome therapeutics are designed to restore enteric health in patients where 98% of the microbiome are found by treating dysbiosis in the enteric microbiome. While having collaboration with top-tier university hospitals, research and development centers, government associations, etc., we keep advancing our pipelines of precision microbiome therapeutics. GenoFocus has been engaging in enzyme solutions business for specialty food, biopharmaceuticals, cosmeceuticals, agriculture, etc through the eco-friendly process using our platform technology. Our enzyme products are developed through molecular evolution using smart library generation and microbial display-based high throughput screening. With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.